Patients With t(8;21)(q22;q22) and Acute Myeloid Leukemia Have Superior Failure-Free and Overall Survival When Repetitive Cycles of High-Dose Cytarabine Are Administered
John C. Byrd(University of Cincinnati), Clara D. Bloomfield(North Shore University Hospital), Maria R. Baer(University of Maryland, Baltimore), Robert J. Mayer(Applied Natural Sciences), Mazin Β. Qumsiyeh(University of Maryland, Baltimore), Andrew J. Carroll(University of Alabama at Birmingham), Joseph O. Moore(Cancer Institute (WIA)), Frederick R. Davey(University of Maryland, Baltimore), Colin G. Edwards(University of Maryland, Baltimore), Richard K. Dodge(St. Jude Children's Research Hospital), Judith Stamberg(University of Maryland, Baltimore), Charles A. Schiffer(Veterans Health Administration)
Cited by 312
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k